PTTG1IP

PTTG1IP (PBF) is a single-spanning transmembrane glycoprotein proto-oncogene that functions as a multifunctional scaffold controlling plasma membrane transporter availability, p53 stability, DNA damage repair gene expression, and cell invasion. It binds and internalizes the sodium iodide symporter (NIS) and monocarboxylate transporter 8 (MCT8) away from the plasma membrane in a process regulated by Src-mediated phosphorylation at Y174, thereby suppressing iodide uptake and thyroid hormone secretion (PMID:23678037, PMID:22535767, PMID:21844185). PTTG1IP interacts with cortactin at the cell leading edge to drive cancer cell invasion, binds p53 to promote its Mdm2-dependent ubiquitination and degradation causing genomic instability, and occupies promoters of DNA damage repair genes including BRCA1, BRCA2, and RAD51 (PMID:27603901, PMID:24506068, PMID:41074439). Its N-glycosylation is required for sorting into extracellular vesicles, and it promotes PTTG1/securin nuclear translocation and possesses independent transforming activity in fibroblasts and nude mice (PMID:39712388, PMID:21450804).

1. 2007 Medium

   Establishing that PTTG1IP functionally represses NIS expression answered whether PBF had a direct role in thyroid iodide handling beyond its known PTTG1 interaction.

   Evidence NIS promoter-reporter assays with defined PAX8-USF1 elements in FRTL-5 and primary human thyroid cells

   PMID:17297475

   Open questions at the time

   • Mechanism of PBF-mediated NIS promoter repression not fully delineated
   • Whether PBF directly contacts NIS protein at this stage unresolved
2. 2008 Low

   An engineered SCF-PBF fusion that degraded PTTG1 via the proteasome demonstrated that PBF can physically recruit PTTG1, clarifying the molecular basis of PBF-PTTG1 interaction.

   Evidence Fusion protein (F-PBF-β-TrCP) co-expression in COS-7/HeLa cells with western blot for PTTG1 degradation

   PMID:18977400

   Open questions at the time

   • Engineered fusion context does not prove endogenous complex formation
   • Stoichiometry and endogenous relevance not established
   • No reciprocal validation of endogenous interaction
3. 2011 High

   In vivo transgenic overexpression proved PBF is a bona fide proto-oncogene that drives thyroid hyperplasia and suppresses NIS, moving beyond cell-based assays to organismal phenotypes; independently, PBF was shown to promote PTTG1 nuclear translocation and transform NIH 3T3 cells.

   Evidence Thyroid-specific PBF transgenic mouse model with IHC, iodide uptake, and primary culture rescue (siRNA); NIH 3T3 transformation and nude mouse assays

   PMID:21450804 PMID:21844185

   Open questions at the time

   • Whether transformation is PTTG1-dependent or independent not resolved
   • Mechanism of Akt/cyclin D1 upregulation downstream of PBF unclear
4. 2012 High

   Discovery that PBF binds and internalizes MCT8 away from the plasma membrane extended its transporter-regulatory function beyond NIS to thyroid hormone efflux, explaining in vivo thyroid hormone accumulation in PBF-Tg mice.

   Evidence Co-immunoprecipitation, cell surface biotinylation, confocal microscopy, and PBF-Tg mouse TH secretion assays

   PMID:22535767

   Open questions at the time

   • Direct binding domain on MCT8 not mapped
   • Whether Y174 phosphorylation also regulates MCT8 internalization untested
5. 2013 High

   Identification of Src as the kinase phosphorylating PBF at Y174, and demonstration that this modification controls PBF plasma membrane dynamics and NIS internalization, provided the first signaling-level regulatory mechanism for PBF function.

   Evidence Mass spectrometry, GST pulldown, Co-IP, Y174A mutagenesis, cell surface biotinylation, PP1 inhibitor rescue of iodide uptake

   PMID:23678037

   Open questions at the time

   • Other potential phosphorylation sites not systematically surveyed
   • Structural basis of Src-PBF recognition unknown
6. 2014 High

   Demonstrating that PBF binds p53 and promotes its Mdm2-dependent ubiquitination, while PBF-Tg thyroids show repression of DNA repair genes and genomic instability, revealed a second oncogenic axis independent of transporter regulation.

   Evidence Co-IP, proximity ligation assay, ubiquitination assay, p53 reporter assays, ISSR-PCR genomic instability, transgenic mouse model

   PMID:24506068

   Open questions at the time

   • Whether PBF directly enhances Mdm2-p53 interaction or acts allosterically unresolved
   • Causal relationship between DDR gene repression and genomic instability not mechanistically dissected
7. 2016 High

   Identification of cortactin as a PBF-interacting partner at the leading edge that is required for PBF-driven invasion established the molecular mechanism linking PBF to cell motility.

   Evidence Co-IP, proximity ligation assay, confocal colocalization, 2D/3D invasion assays, CTTN siRNA rescue, Y174A mutagenesis

   PMID:27603901

   Open questions at the time

   • Whether PBF directly activates cortactin branched-actin nucleation or acts as a scaffold not determined
   • Contribution of PBF-cortactin axis versus PBF-p53 axis to tumor progression in vivo unknown
8. 2017 Medium

   Cancer-associated missense mutations (C51R, R140W) that disrupt protein stability and localization but retain NIS-repressive function showed that PBF's oncogenic activities (invasion, colony formation) and transporter-repressive functions are mechanistically separable.

   Evidence Protein half-life assays, confocal localization, Boyden chamber invasion, colony formation, soft agar, and iodide uptake assays with site-directed mutants

   PMID:28676500

   Open questions at the time

   • Whether these mutations affect cortactin or p53 binding not tested
   • No patient cohort to assess clinical prevalence of these variants
9. 2018 Medium

   Discovery that androgen receptor directly binds the PTTG1IP promoter and drives its expression linked PBF upregulation to androgen signaling, providing a transcriptional mechanism for PBF overexpression in prostate cancer.

   Evidence ChIP at PBF promoter ARE, luciferase reporter, RNAi knockdown of PBF reducing androgen-driven proliferation/invasion in LNCaP cells

   PMID:30569723

   Open questions at the time

   • Whether AR regulation of PBF is relevant in thyroid or breast contexts untested
   • Epigenetic regulation of PTTG1IP locus not explored
10. 2022 Medium

    Identification of Sp4 as a direct transcriptional activator of PTTG1IP via promoter-proximal Sp4 response elements added a second transcription factor to PBF's regulatory circuitry.

    Evidence EMSA confirming direct Sp4 binding, promoter deletion/reporter analysis in HeLa cells

    PMID:36383136

    Open questions at the time

    • Physiological context in which Sp4 regulates PBF not established
    • Interplay between Sp4 and AR at the PTTG1IP promoter unknown
11. 2024 Medium

    Demonstration that N-glycosylation is required for PTTG1IP sorting into extracellular vesicles revealed a new trafficking fate and functional context for the protein beyond plasma membrane and intracellular compartments.

    Evidence Mutagenesis of N-glycosylation sites, EV isolation, functional cargo delivery assays in vitro and in mouse xenograft

    PMID:39712388

    Open questions at the time

    • Endogenous cargo carried by PTTG1IP-positive EVs not identified
    • Whether EV-sorted PBF retains oncogenic signaling in recipient cells unknown
12. 2025 Medium

    ChIP-qPCR showing PBF occupies promoters of BRCA1, BRCA2, RAD51, RAD51AP1, and ATM, combined with the observation that PBF depletion sensitizes cells to radiation-induced DNA damage, provided direct evidence for PBF's role in DNA damage repair gene regulation.

    Evidence Co-IP confirming endogenous PBF-cortactin complex, ChIP-qPCR at DDR promoters, shRNA knockdown with γH2AX and TUNEL assays after irradiation

    PMID:41074439

    Open questions at the time

    • Whether PBF activates or represses DDR gene transcription at these promoters not clarified (contrasts with earlier repression data)
    • Mechanism by which a transmembrane protein occupies gene promoters not explained
    • Not independently replicated

• The mechanism by which a single-pass transmembrane glycoprotein accesses nuclear gene promoters and coordinates its dual membrane-trafficking and transcriptional functions remains unresolved.
• No structural model of PTTG1IP exists
• Nuclear versus membrane pool partitioning mechanism unknown
• Whether PBF's diverse functions (NIS/MCT8 internalization, p53 destabilization, cortactin-mediated invasion, DDR gene regulation, EV sorting) operate in the same or distinct cellular contexts is unexplored